Style | Citing Format |
---|---|
MLA | Heshmatghahdarijani K, et al.. "The Effect of Allium Hirtifolium Bulb on Serum Lipid Profile in Adult Patients With Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial." Complementary Therapies in Clinical Practice, vol. 49, no. , 2022, pp. -. |
APA | Heshmatghahdarijani K, Soltani R, Ghanadian M, Soleymani H (2022). The Effect of Allium Hirtifolium Bulb on Serum Lipid Profile in Adult Patients With Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Complementary Therapies in Clinical Practice, 49(), -. |
Chicago | Heshmatghahdarijani K, Soltani R, Ghanadian M, Soleymani H. "The Effect of Allium Hirtifolium Bulb on Serum Lipid Profile in Adult Patients With Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial." Complementary Therapies in Clinical Practice 49, no. (2022): -. |
Harvard | Heshmatghahdarijani K et al. (2022) 'The Effect of Allium Hirtifolium Bulb on Serum Lipid Profile in Adult Patients With Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial', Complementary Therapies in Clinical Practice, 49(), pp. -. |
Vancouver | Heshmatghahdarijani K, Soltani R, Ghanadian M, Soleymani H. The Effect of Allium Hirtifolium Bulb on Serum Lipid Profile in Adult Patients With Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Complementary Therapies in Clinical Practice. 2022;49():-. |
BibTex | @article{ author = {Heshmatghahdarijani K and Soltani R and Ghanadian M and Soleymani H}, title = {The Effect of Allium Hirtifolium Bulb on Serum Lipid Profile in Adult Patients With Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial}, journal = {Complementary Therapies in Clinical Practice}, volume = {49}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Heshmatghahdarijani K AU - Soltani R AU - Ghanadian M AU - Soleymani H TI - The Effect of Allium Hirtifolium Bulb on Serum Lipid Profile in Adult Patients With Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial JO - Complementary Therapies in Clinical Practice VL - 49 IS - SP - EP - PY - 2022 ER - |